Evidence map›Paper›PMID 41947688›Full record

ArticleJournal of veterinary science2026

Association between chronic kidney disease progression and serum feline pancreatic lipase concentrations in cats.

Jihyun Kim, Youngmin Yun

Abstract read
In one paragraph

Article in Journal of veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jihyun KimCollege of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 63243, Korea.ORCID https://orcid.org/0009-0003-9133-9228
Youngmin YunCollege of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 63243, Korea. dvmyun@jejunu.ac.kr.ORCID https://orcid.org/0000-0003-0695-0843

Funding

Jeju Special Self-Governing Province 2025-RISE-17-001Ministry of Education
6 · The paper itself

Abstract

importanceSerum feline pancreatic lipase (fPL) is used to diagnose pancreatitis, but interpretation is challenging because fPL may be affected by non-pancreatic disease, including reduced renal function.

objectiveTo evaluate the association between chronic kidney disease (CKD) stage and serum fPL in cats and characterize how renal biomarkers relate to fPL.

methodsThis retrospective study evaluated medical records of cats presented to a secondary referral veterinary hospital between February 2024 and March 2025. Inclusion required same-day testing of complete blood count, serum biochemistry, blood gas analysis, urinalysis, serum fPL, and abdominal ultrasonography. CKD staging followed International Renal Interest Society guidelines using serum creatinine, urine specific gravity (USG), and ultrasonography. Nonparametric group comparisons were performed using the Kruskal-Wallis test, and associations between fPL and renal biomarkers were assessed using Spearman's correlation.

resultsfPL increased significantly with advancing CKD stage ( CONCLUSIONS AND RELEVANCE: In this clinical cohort, higher CKD stage was associated with higher serum fPL. Because fPL alone is insufficient to diagnose pancreatitis and may increase with reduced renal function, mild-to-moderate fPL elevations in cats with CKD should be interpreted in the context of clinical signs and pancreatic imaging findings.

Indexed as

Cat DiseasesLipaseRenal Insufficiency, ChronicAnimalsBiomarkersCatsDisease ProgressionFemaleMalePancreasRetrospective StudiesBiomarkersLipaseazotemiaFeline medicinelipasepancreatitisrenal insufficiency

Identifiers

PMID41947688
PMCPMC13062426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.